Press ReleasesRead more
Connecting Patients to Hope
OncoBay is working to assure patients receive the treatments they need, in the communities where they live, from physicians they know and trust, surrounded by the people they love.
We have built a trusted site network to navigate the complexities of novel solutions impacting today’s cancer treatments. Our model provides a broader range of expertise and a larger base of patients.
OncoBay provides the unique advantage of two distinct site relationships:
- Cell Therapy Consortium – With the support of Moffitt Cancer Center, these sites have been specifically vetted and trained by OncoBay to conduct cell therapy trials. These sites have the capabilities, expertise, and resources to execute the complex requirements of CTx studies and enhance access to patients.
- IO Network – These sites have been vetted specifically for their ability to activate quickly, identify large numbers of patients, and integrate successfully within the OncoBay Clinical technology ecosystem. Working with these sites allows unparalleled transparency and efficiency, and many are also capable of working in JIT models.
These specialized networks increase patient access, reduce time, and decrease the expense required to conduct clinical trials.